<DOC>
	<DOCNO>NCT00831987</DOCNO>
	<brief_summary>To observe describe safety Days 0 21 follow injection 2004-2005 formulation inactivate , split-virion influenza vaccine Fluzone® subject age 18-59 year subject age ≥ 60 year . To measure describe immune response ( antibody hemagglutinin ) 21 day follow injection 2004-2005 formulation inactivate , split-virion influenza vaccine Fluzone® , subject age 18-59 year subject age ≥ 60 year .</brief_summary>
	<brief_title>Safety Immunogenicity World Health Organization ( WHO ) Formulation 2004-2005 Fluzone® Vaccine</brief_title>
	<detailed_description>The time onset duration local systemic solicit reaction assess report . Unsolicited adverse event ( include serious adverse event ) collect categorize throughout study period . Antibody level evaluate hemagglutination inhibition ( HI ) assay serum obtain pre-vaccination ( Day 0 ) 21 day post-vaccination , antigens 2004-2005 influenza virus strain : A/New Caledonia/20/99 ( H1N1 ) , A/Wyoming/03/2003 ( H3N2 ) , B/Jiangsu/10/2003 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Participant age 18 year old . Participant able attend schedule visit comply study procedure entire duration study . Participant reasonably good health assess investigator . Participant willing able meet protocol requirement . Participant willing able give inform consent . Exclusion Criteria : Selfreported allergy egg protein , chicken protein , one constituent vaccine , thimerosal formaldehyde . An acute illness without fever ( temperature &gt; 100.4°F ) 72 hour precede enrollment trial . Clinically significant finding vital sign ( include temperature &gt; 100.4°F ) review system . Selfreported history severe adverse event influenza vaccine . Vaccination influenza 6 month precede enrollment study . Any vaccination 14 day precede enrollment study schedule Visit 1 Visit 3 . Participation experimental drug vaccine trial within 30 day precede enrollment study . Immunogenicity immunosuppressive therapy ( include systemic steroid use 2 week ) , cancer chemotherapy , radiation therapy time enrollment , plan period study , time within past 3 month . Receipt blood blood product within 3 month precede enrollment study . Diabetes mellitus require pharmacological control . Any condition opinion investigator would pose health risk subject enrol , could interfere evaluation vaccine . Person deprive freedom administrative court order ( legal medical guardian ) . For woman childbearing age , positive urine pregnancy test , breast feeding , use medically approve reliable form contraception ( oral contraceptive double barrier method ) duration trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Fluzone®</keyword>
	<keyword>Influenza</keyword>
	<keyword>Adults</keyword>
</DOC>